Bayer promotes 2 pharma execs
Bayer has promoted two of its seasoned pharmacy leaders.
Nelson Ambrogio, formerly the senior vice president, general manager of Women’s Healthcare has been appointed to the role of senior vice president, general manager of Oncology.
John Berrios, formerly vice president of commercial operations, will become the senior vice president, general manager of Women’s Healthcare.
Ambrogio and Berrios will both serve on the U.S. Pharmaceutical Leadership Team and report directly to Sebastian Guth, Bayer’s president of pharmaceuticals, Americas Region.
“Nelson and John are passionate, well-respected leaders in the pharmaceutical industry and have a proven track record of launching products, developing rising leaders and driving growth,” said Guth. “The U.S. Pharmaceuticals Business is central to Bayer’s success. I’m confident that under their leadership, the Oncology and Women’s Healthcare franchises will continue on a growth path and further strengthen our overall business in the U.S.”
Prior to his current appointment, Ambrogio was the senior vice president and GM of the Women’s Healthcare business in the United States, overseeing the Sales and Marketing teams for the company’s contraceptive franchise. Prior to WHC, Ambrogio held multiple leadership positions within Bayer worldwide, including general manager of Bayer in Australia and New Zealand (2015-2019), Managing Director of Bayer in Portugal (2012-2015), Head of the General Medicine business in Brazil (2010-2012) and Executive Board Support of Strategy and Human Resources in Germany (2007-2010). Ambrogio began his career in Sales and Marketing at Schering in Uruguay, South America. He holds a bachelor’s degree from the Universidad del Valle de Mexico, and a Master’s of Business Administration from the Business School Sao Paulo.
After five years at Bayer, Berrios will lead the Women’s Healthcare business in the United States starting May 1. Since joining Bayer in 2016, Berrios has held multiple leadership roles in market access and operations. In his previous role, as vice president of commercial operations, he led enterprise-wide operations for the pharmaceutical division, as well as advanced the company’s digital transformation by building a best-in-class in-house media team. Most recently, Berrios successfully integrated a new digital customer engagement program across commercial, market access and medical.
Prior to joining Bayer, Berrios spent more than 15 years at AstraZeneca in various roles, including sales, market access, and marketing positions. He served as the senior director of patient engagement, where he was responsible for leading the marketing and patient engagement programs across the company’s portfolio including cardiovascular, diabetes, respiratory, specialty and oncology divisions.
Berrios also holds an MBA from St. John’s University and earned his bachelor’s degree from the University of New York at Albany.